Generate a tailored SOP for Dr. Dongli Liu. Improve your application with a focused, well-structured draft.
Dongli Liu is a postdoctoral researcher with extensive expertise in molecular cell biology and patient-derived primary cell culture. With strong bioinformatics skills, Liu specializes in next-generation sequencing (NGS). Since joining the Gynaecological Cancer Research Group at the University of New South Wales in 2018, Liu has led multiple research projects aimed at identifying prognostic biomarkers and novel therapies for ovarian and endometrial cancers. Liu's work has primarily focused on developing patient-derived 3D cancer models to test novel therapies and understand the molecular subtypes of malignancies. Liu has contributed significantly to advancing research in the field of gynaecological cancers, working on innovative approaches to improve patient outcomes through targeted research and collaboration.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.